Private equity firms circle Australia’s Healthscope

Australian private healthcare provider Healthscope is considering buy-out offers from two more bidders, including more private equity firms, as competition for the company heats up.

  • 31 May 2010

Two new bidders have made offers valuing the company at A$5.80 a share, or A$1.84bn ($1.56bn) in total, Healthscope announced on Monday.

KKR is among the new bidders, potentially in partnership with CVC. The other bidder is understood to be US private healthcare group Tenet Healthcare.

The two bids ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 3,136 9 13.35
2 Citi 2,562 6 10.90
3 Goldman Sachs 2,150 3 9.15
4 Credit Suisse 1,822 6 7.75
5 Societe Generale 1,814 4 7.72

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 22 May 2017
1 Citi 41,255.30 117 12.99%
2 Bank of America Merrill Lynch 37,631.92 109 11.85%
3 Wells Fargo Securities 32,082.26 89 10.11%
4 JPMorgan 20,969.41 64 6.60%
5 Credit Suisse 16,754.47 44 5.28%